ea0028oc5.5 | Growth, tumours and pituitary | SFEBES2012
Pinato David
, Ramachandran Radha
, Toloue Kalami Toussi Samin
, Vergine Marco
, Ngo Nyethane
, Sharma Rohini
, Khoo Bernard
, Meeran Karim
, Palazzo Fausto
, Martin Niamh
, Dina Roberto
, Tan Tricia
Backgeound and Aims: Phaeochromocytomas (PCC) and paragangliomas (PGL) are mostly benign sympathoadrenal tumours. However, there are no available markers to predict a malignant course. Since hypoxia is involved in the pathogenesis of these tumours, we aimed to qualify the relevance of the mammalian Target of Rapamycin (m-TOR) and hypoxic pathways in benign and malignant PCC/PGL.Methods: Tissue microarray (TMA) blocks were constructed with 80 PCC/PGL, inc...